AAUM (Average Assets Under Management) of ₹117.84 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 63.1% | 63.3% | ▲ +0.2% |
| Healthcare Services | 27.5% | 25.7% | ▼ -1.8% |
| Chemicals & Petrochemicals | 2.8% | 3.0% | ▲ +0.2% |
| Insurance | 0.9% | 1.4% | ▲ +0.5% |
| Retailing | 0.7% | 0.7% | ● +0.0% |
| IT - Services | 0.5% | 0.5% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 63.3% | 62.8% | ▼ -0.5% |
| Healthcare Services | 25.7% | 24.6% | ▼ -1.1% |
| Chemicals & Petrochemicals | 3.0% | 3.2% | ▲ +0.2% |
| Insurance | 1.4% | 2.1% | ▲ +0.7% |
| Retailing | 0.7% | 1.0% | ▲ +0.3% |
| Healthcare Equipment & Supplies | 0.0% | 0.8% | ▲ +0.8% |
| IT - Services | 0.5% | 0.4% | ● -0.1% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | Symbiotec Pharmalab Limited ₹1.43 Cr |
Pharmaceuticals & Biotechnology | 1.10% |
| 2 | Molbio Diagnostics Ltd. ₹1.04 Cr |
Healthcare Equipment & Supplies | 0.80% |
| # | Stock | Sector | Last Weight (Aug 2026) |
|---|---|---|---|
| 1 | Pfizer Limited ₹2.65 Cr |
Pharmaceuticals & Biotechnology | 2.12% |
| 2 | Dr Agarwals Health Care Limited ₹1.07 Cr |
Healthcare Services | 0.86% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | IPCA Laboratories Limited ₹2.50 Cr |
Pharmaceuticals & Biotechnology | 0.51% | 1.92% | +1.41% |
| 2 | Gland Pharma Limited ₹1.95 Cr |
Pharmaceuticals & Biotechnology | 0.73% | 1.50% | +0.77% |
| 3 | ICICI Lombard General Insurance Company Limited ₹2.74 Cr |
Insurance | 1.40% | 2.10% | +0.70% |
| 4 | Dr.Agarwals Eye Hospital Limited ₹2.42 Cr |
Healthcare Services | 1.20% | 1.86% | +0.66% |
| 5 | Zydus Lifesciences Limited ₹2.66 Cr |
Pharmaceuticals & Biotechnology | 1.51% | 2.04% | +0.53% |
| 6 | Lupin Limited ₹2.52 Cr |
Pharmaceuticals & Biotechnology | 1.42% | 1.93% | +0.51% |
| 7 | Dr. Lal Path Labs Limited ₹5.64 Cr |
Healthcare Services | 3.93% | 4.33% | +0.40% |
| 8 | Fortis Healthcare Limited ₹1.90 Cr |
Healthcare Services | 1.10% | 1.46% | +0.36% |
| 9 | Abbott India Limited ₹4.06 Cr |
Pharmaceuticals & Biotechnology | 2.83% | 3.12% | +0.29% |
| 10 | Lenskart Solutions Limited ₹1.28 Cr |
Retailing | 0.71% | 0.99% | +0.28% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Rubicon Research Limited ₹3.90 Cr |
Pharmaceuticals & Biotechnology | 4.01% | 2.99% | -1.02% |
| 2 | Sun Pharmaceutical Industries Limited ₹13.35 Cr |
Pharmaceuticals & Biotechnology | 10.74% | 10.25% | -0.49% |
| 3 | Divi's Laboratories Limited ₹13.50 Cr |
Pharmaceuticals & Biotechnology | 10.85% | 10.36% | -0.49% |
| 4 | Manipal Health Enterprises Ltd ₹4.79 Cr |
Healthcare Services | 4.12% | 3.68% | -0.44% |
| 5 | Torrent Pharmaceuticals Limited ₹11.06 Cr |
Pharmaceuticals & Biotechnology | 8.86% | 8.49% | -0.37% |
| 6 | Neuland Laboratories Limited ₹3.79 Cr |
Pharmaceuticals & Biotechnology | 3.26% | 2.91% | -0.35% |
| 7 | Aster DM Healthcare Limited ₹3.34 Cr |
Healthcare Services | 2.89% | 2.56% | -0.33% |
| 8 | Jupiter Life Line Hospitals Limited ₹1.90 Cr |
Healthcare Services | 1.77% | 1.46% | -0.31% |
| 9 | Max Healthcare Institute Limited ₹6.14 Cr |
Healthcare Services | 4.96% | 4.71% | -0.25% |
| 10 | Global Health Limited ₹1.99 Cr |
Healthcare Services | 1.72% | 1.52% | -0.20% |
31 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹13.50 Cr |
Pharmaceuticals & Biotechnology |
10.36%
|
|
| 2 |
₹13.35 Cr |
Pharmaceuticals & Biotechnology |
10.25%
|
|
| 3 |
₹11.06 Cr |
Pharmaceuticals & Biotechnology |
8.49%
|
|
| 4 |
₹6.46 Cr |
Pharmaceuticals & Biotechnology |
4.96%
|
|
| 5 |
₹6.14 Cr |
Healthcare Services |
4.71%
|
|
| 6 |
₹5.64 Cr |
Healthcare Services |
4.33%
|
|
| 7 |
₹5.27 Cr |
Pharmaceuticals & Biotechnology |
4.04%
|
|
| 8 |
₹4.79 Cr |
Healthcare Services |
3.68%
|
|
| 9 |
₹4.22 Cr |
Chemicals & Petrochemicals |
3.24%
|
|
| 10 |
₹4.06 Cr |
Pharmaceuticals & Biotechnology |
3.12%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.